Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marina Johnson

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Vaccine|April 12, 2023
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infantsDavid Goldblatt, Nick J Andrews, Carmen L Sheppard, et al.
Scientific Reports|May 20, 2022
Transmission dynamics of SARS-CoV-2 in a strictly-Orthodox Jewish community in the UKWilliam Waites, Carl A B Pearson, Katherine M Gaskell, et al.
Frontiers in Oncology|February 9, 2026
Case Report: Novel ASAP1::BRAF fusion in a young adult with low-grade temporal lobe gliomaPetroula Gerasimou, Dimitris Vrachnos, Yiannos Kyprianou, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Comprehensive antibody profiling of mRNA vaccination in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Iscience|January 18, 2024
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivityNtombi Benede, Marius B Tincho, Avril Walters, et al.
Nature Cancer|March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
Nature|November 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Vaccine|April 12, 2023
Pneumococcal carriage following PCV13 delivered as one primary and one booster dose (1 + 1) compared to two primary doses and a booster (2 + 1) in UK infantsDavid Goldblatt, Nick J Andrews, Carmen L Sheppard, et al.
Scientific Reports|May 20, 2022
Transmission dynamics of SARS-CoV-2 in a strictly-Orthodox Jewish community in the UKWilliam Waites, Carl A B Pearson, Katherine M Gaskell, et al.
Frontiers in Oncology|February 9, 2026
Case Report: Novel ASAP1::BRAF fusion in a young adult with low-grade temporal lobe gliomaPetroula Gerasimou, Dimitris Vrachnos, Yiannos Kyprianou, et al.
Biorxiv : the Preprint Server for Biology|January 12, 2022
Comprehensive antibody profiling of mRNA vaccination in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Science Translational Medicine|July 26, 2022
SARS-CoV-2 mRNA vaccination elicits robust antibody responses in childrenYannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, et al.
Iscience|January 18, 2024
Distinct T cell polyfunctional profile in SARS-CoV-2 seronegative children associated with endemic human coronavirus cross-reactivityNtombi Benede, Marius B Tincho, Avril Walters, et al.
Nature Cancer|March 25, 2022
Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO studySean H Lim, Beth Stuart, Debora Joseph-Pietras, et al.
Nature|November 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
BMC Medicine|December 15, 2025
A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunityConstanza Méndez, Linmar Rodríguez-Guilarte, Pablo A Palacios, et al.
Pageof 4